Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hodgkin Disease × Protons × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Meningioma 2 HER2-positive Breast Cancer 2 Glioma 2 Glioblastoma 2 Chordoma 2 Brain Neoplasms 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sarcoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Radiation Injuries 1 Pituitary Neoplasms 1 Oligodendroglioma 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lung Neoplasms 1

Interventions

Cyclophosphamide 179 fludarabine phosphate 105 Etoposide 100 Peripheral Blood Stem Cell Transplantation 90 Filgrastim 82 Mycophenolic Acid 80 Doxorubicin 78 Whole-Body Irradiation 73 Melphalan 73 Radiotherapy 68 Brentuximab Vedotin 68 Tacrolimus 66 fludarabine 63 Busulfan 63 Vinblastine 59 Cyclosporine 58 Rituximab 56 Dacarbazine 49 Gemcitabine 48 Granulocyte Colony-Stimulating Factor 47 Bleomycin 47 Vincristine 43 Antilymphocyte Serum 43 Prednisone 41 Nivolumab 40 Cytarabine 40 Methotrexate 39 Carmustine 34 pembrolizumab 31 Sirolimus 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02070393 2015-02-04

Breast Sparing

Indiana University

Phase EARLY_PHASE1 Terminated

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡